The PBMC derived from twenty-five participants with T2DM (34.2%) showed expression of all osteoblast-specific marker genes, including BGLAP, COL1A1, and the RUNX2/PPARγ ratio, indicating differentiation of the cells towards osteoblasts. The gene discussed is RUNX2; the disease is type 2 diabetes mellitus.